During the past decade, Clinical Advancement Center, PLLC conducted 41 clinical trials. In the 10-year time frame, 41 clinical trials started and 20 clinical trials were completed, i.e. on average, 48.8% percent of trials that started reached the finish line to date. In the past 5 years, 24 clinical trials started and 16 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Clinical Advancement Center, PLLC" #1 sponsor was "Bayer" with 7 trials, followed by "La Jolla Pharmaceutical Company" with 4 trials sponsored, "Reata Pharmaceuticals, Inc." with 4 trials sponsored, "Boehringer Ingelheim" with 3 trials sponsored and "C. R. Bard" with 3 trials sponsored. Other sponsors include 20 different institutions and companies that sponsored additional 27 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Clinical Advancement Center, PLLC" #1 collaborator was "Akebia Therapeutics" with 1 trials as a collaborator, "Canadian VIGOUR Centre" with 1 trials as a collaborator, "Centessa Pharmaceuticals plc" with 1 trials as a collaborator, "Cyclerion Therapeutics" with 1 trials as a collaborator and "Duke Clinical Research Institute" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "Clinical Advancement Center, PLLC" are "Chronic Kidney Disease" (8 trials), "Chronic Kidney Diseases" (5 trials), "Diabetic Kidney Disease" (4 trials), "Autosomal Dominant Polycystic Kidney" (3 trials) and "ADPKD" (2 trials). Many other conditions were trialed in "Clinical Advancement Center, PLLC" in a lesser frequency.

Most popular intervention types in "Clinical Advancement Center, PLLC" are "Drug" (42 trials), "Device" (2 trials), "Other" (2 trials), "Biological" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (23 trials), "GCS-100" (4 trials), "Finerenone (BAY94-8862)" (3 trials), "BI 685509" (2 trials) and "Bardoxolone methyl oral capsule" (2 trials). Other intervention names were less common.

The vast majority of trials in "Clinical Advancement Center, PLLC" are 45 trials for "All" genders.

Currently, there are NaN active trials in "Clinical Advancement Center, PLLC". undefined are not yet recruiting, 9 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 23 completed trials in Clinical Advancement Center, PLLC, 1 suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Clinical Advancement Center, PLLC, 4 "Phase 1" clinical trials were conducted, 25 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 2 trials that are defined as “Not Applicable".